The purpose of this study is to evaluate the impact of replacing usual snacks with alternative snack foods on gut health in a population of habitual snackers with low fibre intake.
Diet is a crucial target for the improvement of human health. In the modern world, diets are diverse and diet related diseases are becoming more and more common. In particular, it is becoming increasingly apparent that the bacteria that live in the gut are strongly linked to both diet and health. Bacteria in the gut can be beneficial or harmful, and the health of the gut relies on the beneficial bacteria outnumbering the harmful ones. Diet has a great impact on the bacterial composition of the gut. In turn, the gut bacteria play diverse roles in human health, influencing not only the gut but also the health of the immune system, heart and brain. Therefore, optimising the composition of the gut bacterial is vital to human health and wellbeing. It has been shown that snacks between meals contributes 420 - 480 calories per day, almost a quarter of the recommended intake. Therefore, snack choices are an area of diet and lifestyle that have the potential to influence diet and in turn the health of our gut and gut bacteria. We would like to assess the effect of replacing usual snacks with alternative snack foods that we believe have benefits for gut health. The primary aim of the study is to investigate whether the replacement of usual snacks has an effect on gut bacterial composition, specifically the abundance of Bifidobacteria. Secondary aims include the effect of the intervention snacks on additional measures of gut health such as gut transit time, the frequency and consistency of bowel movements and gut symptoms e.g. heartburn, nausea, belching etc. The effect of snack foods on metabolites in the blood (e.g. glucose, insulin, lipids) will also be determined. Finally the impact of snack replacement on mood and quality of life will be assessed.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Enrollment
87
To be eaten instead of regular snacks twice a day for 4 weeks.
To be eaten instead of regular snacks twice a day for 4 weeks.
To be eaten instead of regular snacks twice a day for 4 weeks.
King's College London Waterloo Campus
London, United Kingdom
Faecal bifidobacteria
Measured by 16S community profiling (Illumina Miseq) of bacterial genomic DNA isolated from participant stool samples
Time frame: Baseline
Faecal bifidobacteria
Measured by 16S community profiling (Illumina Miseq) of bacterial genomic DNA isolated from participant stool samples
Time frame: Day 28
Whole gut transit time
Measured using the SmartPill wireless motility capsule
Time frame: Baseline
Whole gut transit time
Measured using the SmartPill wireless motility capsule
Time frame: Day 28
Regional gut transit time
Measured using the SmartPill wireless motility capsule
Time frame: Baseline
Regional gut transit time
Measured using the SmartPill wireless motility capsule
Time frame: Day 28
Regional gut pH
Measured using the SmartPill wireless motility capsule
Time frame: Baseline
Regional gut pH
Measured using the SmartPill wireless motility capsule
Time frame: Day 28
Faecal gut microbiota (alpha- and beta-diversity)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Measured by 16S community profiling (Illumina Miseq) of bacterial genomic DNA isolated from participant stool samples
Time frame: Baseline
Faecal gut microbiota (alpha- and beta-diversity)
Measured by 16S community profiling (Illumina Miseq) of bacterial genomic DNA isolated from participant stool samples
Time frame: Day 28
Faecal short-chain fatty acids (SCFA)
Measured by gas liquid chromatography of stool sample
Time frame: Baseline
Faecal short-chain fatty acids (SCFA)
Measured by gas liquid chromatography of stool sample
Time frame: Day 28
Faecal water
Measured by lyophilization of stool sample
Time frame: Baseline
Faecal water
Measured by lyophilization of stool sample
Time frame: Day 28
Faecal volatile organic compounds
Measured by gas-chromatography mass-spectrometry of stool samples
Time frame: Baseline
Faecal volatile organic compounds
Measured by gas-chromatography mass-spectrometry of stool samples
Time frame: Day 28
Gut symptoms
Gastrointestinal symptoms rating scale (7-day; questionnaire)
Time frame: Week 0
Gut symptoms
Gastrointestinal symptoms rating scale (7-day; questionnaire)
Time frame: week 4
Stool frequency
Bristol stool form scale (7-day; questionnaire)
Time frame: Week 0
Stool frequency
Bristol stool form scale(7-day; questionnaire)
Time frame: Week 4
Dietary intake
7-day food diary
Time frame: Week 0
Dietary intake
7-day food diary
Time frame: Week 4
Quality of life
SF-36 questionnaire
Time frame: Baseline
Quality of life
SF-36 questionnaire
Time frame: Day 28
Mood
Hospital anxiety and depression scale
Time frame: Baseline
Mood
Hospital anxiety and depression scale
Time frame: Day 28
Physical activity
Recent physical activity questionnaire
Time frame: Baseline
Physical activity
Recent physical activity questionnaire
Time frame: Day 28
Dietary metabolites (various)
Measured in blood sample
Time frame: Baseline
Dietary metabolites (various)
Measured in blood sample
Time frame: Day 28
Particle size of masticated snack foods
Mechanical sieving and laser diffraction of masticated snack foods
Time frame: Day 28